Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy Subjects
Clinical trial NCT03874234 · TERMINATED
Trial details
- NCT number
- NCT03874234
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-30
- Primary completion
- 2019-10-17
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.